Started May 24, 2011 0 Replies 0 Favorites
Prosensa is currently conducting a clinical study to investigate the effect of PRO044 in boys with Duchenne muscular dystrophy, who have a dystrophin gene mutation amenable to an exon 44 skip.…Continue
Started this discussion. Last reply by arnold May 5, 2011. 1 Reply 0 Favorites
A new drug for the muscle-wasting disease Duchenne muscular dystrophy has shown significant benefits in mice, opening the door for clinical trials…Continue
Started Nov 4, 2010 0 Replies 0 Favorites
Results from the recent AVI-4658 study have been positive so far and are now awaiting further analysis in America by the sponsor AVI BioPharma. Two families that have participated in the trial in the…Continue
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Comment Wall (2 comments)
You need to be a member of PPMD Community to add comments!
Join PPMD Community
Gracias Wilfredo,
Hello, my name is Jefferson and DMD have, as I do to be able to talk to you? Excuse my way of speaking but I need to talk to someone who can help me. I am new to this networking site and do not know how to use it perfectly. I am using google translator, if you can speak in Spanish.